Home | | | Search | | | Browse | | | Resources | | | Help | | | What's New | | | About |
---|
Biliary Atresia Research Consortium
This study is not yet open for patient recruitment.
Sponsored by: | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
---|---|
Information provided by: | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
Purpose
Biliary atresia and idiopathic neonatal hepatitis are the most common causes of jaundice and hyperbilirubinemia that continue beyond the newborn period. The long term goal of the Biliary Atresia Research Consortium (BARC) is to establish a database of clinical information and serum and tissue samples from children with biliary atresia (BA) and idiopathic neonatal hepatitis (INH) to facilitate research and to perform clinical, epidemiological and therapeutic trials in these two important pediatric liver diseases.
Condition |
---|
Biliary Atresia Cholestasis |
MedlinePlus related topics: Bile Duct Diseases; Birth Defects; Digestive Diseases
Study Type: Observational
Study Design: Natural History, Longitudinal, Defined Population, Retrospective/Prospective Study
Eligibility
Ages Eligible for Study: up to 6 Months, Genders Eligible for Study: Both
Criteria
Location Information
More Information
Biliary Atresia Research Consortium website
U.S. National Library of Medicine, Contact NLM Customer Service | ||||||||||||||
National Institutes of Health, Department of Health & Human Services | ||||||||||||||
Copyright, Privacy, Accessibility, Freedom of Information Act |